|
Volumn 15, Issue SUPPL. 1, 2003, Pages 161-166
|
Acute stroke
|
Author keywords
Stroke; Treatment
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
HEPARIN DERIVATIVE;
INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY;
MONOCLONAL ANTIBODY;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NEUROPROTECTIVE AGENT;
SODIUM CHANNEL BLOCKING AGENT;
STREPTOKINASE;
ACUTE DISEASE;
AGED;
BRAIN ANGIOGRAPHY;
BRAIN BLOOD FLOW;
BRAIN HEMORRHAGE;
BRAIN PROTECTION;
CEREBROVASCULAR DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIFFUSION WEIGHTED IMAGING;
DRUG EFFICACY;
FIBRINOLYTIC THERAPY;
HUMAN;
MAJOR CLINICAL STUDY;
META ANALYSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
SIDE EFFECT;
STROKE;
TREATMENT OUTCOME;
ACUTE DISEASE;
AGED;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ASPIRIN;
BRAIN;
CEREBROVASCULAR ACCIDENT;
CEREBROVASCULAR CIRCULATION;
FIBRINOLYTIC AGENTS;
HUMANS;
NEUROPROTECTIVE AGENTS;
PLATELET AGGREGATION INHIBITORS;
STREPTOKINASE;
|
EID: 0141485224
PISSN: 10416102
EISSN: None
Source Type: Journal
DOI: 10.1017/S104161020300913X Document Type: Conference Paper |
Times cited : (4)
|
References (3)
|